Literature DB >> 31955218

Prevalence and risk factors for postoperative delirium in patients with colorectal carcinoma: a systematic review and meta-analysis.

Zheng Yang1, Xiao-Feng Wang1, Long-Fei Yang1, Chen Fang1, Xiao-Ke Gu2, Hui-Wen Guo3.   

Abstract

OBJECTIVE: Postoperative delirium (POD) is a common, but severe complication in elderly patients undergoing surgery for colorectal cancer, but the prevalence and potential risk factors for POD were not well established. Therefore, a meta-analysis was preformed to clarify the prevalence and risk factors of POD in patients undergoing surgery for colorectal cancer.
METHODS: PubMed, Embase, and the Cochrane Library were systematically searched on August 2019. Studies were included if they reported the prevalence and risk factors of POD in patients undergoing colorectal cancer surgery. The guidelines for critically appraising studies of prevalence or incidence of a health problem were used to assess the quality of included studies. Pooled odds ratios (ORs) for individual risk factors were estimated using the Mantel-Haenszel methods in random effect model. Sensitive analyses based on different inclusion criteria were conducted to explore whether the current meta-analysis was enough credible and robust.
RESULTS: Seventeen studies totaling 4472 patients undergoing colorectal cancer surgery were included. The pooled prevalence of POD is 14% (95% CI = 12-17%). Twelve significant risk factors were identified in pooled analysis including older age (OR = 1.10), sex (OR = 1.87), history of psychiatric disease (OR = 6.47), comorbidities (OR = 2.17), prognostic nutritional index (OR = 1.12), physical status (OR = 1.27), American Society of Anesthesiologists Score (ASA Scores) (OR = 1.65), history of alcohol abuse (OR = 2.23), postoperative pain management (OR = 1.91), perioperative blood transfusion (OR = 2.37), cognitive status (OR = 1.91), and lower serum level of albumin (OR = 0.58).
CONCLUSIONS: POD is a frequent complication in patients undergoing surgery with colorectal cancer. Several risk factors including history of psychiatric disease, transfusion, comorbidities, male gender, and old age were significant predictors for POD.

Entities:  

Keywords:  Coloretal cancer; Delirium; Meta-analysis; Prevalence; Risk factor

Year:  2020        PMID: 31955218     DOI: 10.1007/s00384-020-03505-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  45 in total

Review 1.  Critical appraisal of the health research literature: prevalence or incidence of a health problem.

Authors:  P L Loney; L W Chambers; K J Bennett; J G Roberts; P W Stratford
Journal:  Chronic Dis Can       Date:  1998

2.  Risk factors for postoperative delirium in elderly patients with colorectal cancer.

Authors:  Mitsuyoshi Tei; Masataka Ikeda; Naotsugu Haraguchi; Ichiro Takemasa; Tsunekazu Mizushima; Hideshi Ishii; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

3.  Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery.

Authors:  Antoine Brouquet; Tristan Cudennec; Stéphane Benoist; Sophie Moulias; Alain Beauchet; Christophe Penna; Laurent Teillet; Bernard Nordlinger
Journal:  Ann Surg       Date:  2010-04       Impact factor: 12.969

4.  EFFECT OF PREOPERATIVE PAIN AND DEPRESSIVE SYMPTOMS ON THE DEVELOPMENT OF POSTOPERATIVE DELIRIUM.

Authors:  Cyrus M Kosar; Patricia A Tabloski; Thomas G Travison; Richard N Jones; Eva M Schmitt; Margaret R Puelle; Jennifer B Inloes; Jane S Saczynski; Edward R Marcantonio; David Meagher; M Carrington Reid; Sharon K Inouye
Journal:  Lancet Psychiatry       Date:  2014-11       Impact factor: 27.083

5.  Risk factors for postoperative delirium after colorectal surgery for carcinoma.

Authors:  Rosalia Patti; Michele Saitta; Giacomo Cusumano; Giuseppe Termine; Gaetano Di Vita
Journal:  Eur J Oncol Nurs       Date:  2011-02-17       Impact factor: 2.398

6.  Adverse outcomes of geriatric patients undergoing abdominal surgery who are at high risk for delirium.

Authors:  Sabha Ganai; K Francis Lee; Andrea Merrill; Maggie H Lee; Sandra Bellantonio; Maura Brennan; Peter Lindenauer
Journal:  Arch Surg       Date:  2007-11

7.  Incidence of postoperative delirium is high even in a population without known risk factors.

Authors:  Andrea Saporito; Evelina Sturini
Journal:  J Anesth       Date:  2013-09-26       Impact factor: 2.078

8.  Multimodal prehabilitation to reduce the incidence of delirium and other adverse events in elderly patients undergoing elective major abdominal surgery: An uncontrolled before-and-after study.

Authors:  T L Janssen; E W Steyerberg; J C M Langenberg; C C H A van Hoof- de Lepper; D Wielders; T C J Seerden; D C de Lange; J H Wijsman; G H Ho; P D Gobardhan; R van Alphen; L van der Laan
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

Review 9.  Depression and postoperative complications: an overview.

Authors:  Mohamed M Ghoneim; Michael W O'Hara
Journal:  BMC Surg       Date:  2016-02-02       Impact factor: 2.102

Review 10.  Meta-analysis of Prevalence and Risk Factors for Delirium After Transcatheter Aortic Valve Implantation.

Authors:  Erica Tilley; Peter J Psaltis; Tobias Loetscher; Daniel H Davis; Stephanie L Harrison; Susan Kim; Hannah A D Keage
Journal:  Am J Cardiol       Date:  2018-09-08       Impact factor: 2.778

View more
  2 in total

Review 1.  Perioperative neurocognitive disorders: A narrative review focusing on diagnosis, prevention, and treatment.

Authors:  Hao Kong; Long-Ming Xu; Dong-Xin Wang
Journal:  CNS Neurosci Ther       Date:  2022-06-01       Impact factor: 7.035

2.  Outcome, demography and resource utilization in ICU Patients with delirium and malignancy.

Authors:  Mattia Sieber; Alain Rudiger; Maria Schubert; Dominique Bettex; Reto Schüpbach; Bernard Krüger
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.